Ovarian cancer (OC) is a common gynecological cancer worldwide. Unfortunately, the lack
of early detection methods translates into a substantial cohort of women grappling with the …

The tumor microenvironment fuels tumorigenesis and induces the development of
resistance to anticancer drugs. A growing number of reports support that the tumor …

Abstract Platinum (PT)-resistant Epithelial Ovarian Cancer (EOC) grows as a metastatic
disease, disseminating in the abdomen and pelvis. Very few options are available for PT …

Cancer-derived small extracellular vesicles (sEVs) are capable of modifying the tumor
microenvironment and promoting tumor progression. Ovarian cancer (OvCa) is a lethal …

Breast cancer has the highest global incidence and mortality rates among all cancer types.
Abnormal expression of the Annexin family has been observed in different malignant tumors …

Chemotherapy is a critical treatment for endocrine-related cancers; however,
chemoresistance and disease recurrence remain a challenge. The interplay between cancer …

Ovarian cancer (OC) is a deadly disease. The poor prognosis and high lethality of OC are
attributed to its high degrees of aggressiveness, resistance to chemotherapy and recurrence …

Background Endometriosis is a common cause of endometrial-type mucosa outside the
uterine cavity with symptoms such as painful periods, chronic pelvic pain, pain with …

Epithelial ovarian cancer is the most lethal gynecologic malignancy with a 5-year survival
rate of only 48%. While most ovarian cancer patients respond to chemotherapy initially …

High-grade serous ovarian carcinoma (HGSOC) is responsible for the majority of ovarian
cancer-associated deaths. PARP (poly-(ADP-ribose) polymerase) inhibitors …